The revenue guidance provided by NeuroPace is closely aligned with analysts' estimates, indicating a positive outlook for the company's financial performance in 2024. The detailed breakdown of expected gross margin and operating expenses, including the significant portion allocated to stock-based compensation, provides a clear picture of the company's cost management and profitability potential. This transparency and alignment with expectations are likely to foster investor confidence, potentially leading to a positive short-term impact on NPCE's stock price.